DSM-Firmenich AG
AEX:DSFIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DSM-Firmenich AG
Total Equity
DSM-Firmenich AG
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Total Equity
€18.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sika AG
F:SIKA
|
Total Equity
CHf6.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
|
C
|
Clariant AG
SIX:CLN
|
Total Equity
CHf2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Givaudan SA
SIX:GIVN
|
Total Equity
CHf4.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Total Equity
CHf1.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Total Equity
CHf1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
DSM-Firmenich AG
Glance View
DSM-Firmenich AG is the culmination of a merger between two titans in their respective fields: DSM, a Dutch multinational known for its prowess in health, nutrition, and sustainable living, and Firmenich, a Swiss firm renowned for its legacy in fragrances and flavors. This strategic union blends DSM's strengths in innovative biotechnology and sustainability with Firmenich's expertise in creating unique sensory experiences. As a combined entity, DSM-Firmenich AG operates on the cutting edge of scientific innovation, catering to a diverse array of industries including food and beverages, personal care, and health products. The synergy of DSM's leadership in sustainable solutions with Firmenich's artistry in scent and flavor not only results in high-quality consumer products but also pushes the envelope in terms of environmental responsibility and human health. The company's business model thrives on innovation and a deep understanding of consumer needs. It leverages its extensive research and development capabilities to produce solutions that enhance the taste, texture, and nutritional value of food, alongside creating signature scents for personal and home care products. By consistently investing in technology and sustainable practices, DSM-Firmenich generates revenue through a broad portfolio of offerings that cater to global clients ranging from multinational corporations to niche brands. Their growth is anchored in delivering products that resonate with consumers' increasing demands for sustainability and authenticity, ensuring that every product not only meets the highest standards of quality but also aligns with the values of a rapidly changing world.
See Also
What is DSM-Firmenich AG's Total Equity?
Total Equity
18.2B
EUR
Based on the financial report for Dec 31, 2025, DSM-Firmenich AG's Total Equity amounts to 18.2B EUR.
What is DSM-Firmenich AG's Total Equity growth rate?
Total Equity CAGR 3Y
19%
Over the last year, the Total Equity growth was -19%. The average annual Total Equity growth rates for DSM-Firmenich AG have been 19% over the past three years .